CAS: 1351185-54-0
4-[(R)-3-[4-Cyano-3-(trifluoromethyl)phenyl]-4-oxo-2-thioxo-7-oxa-1,3-diazaspiro[4.4]non-1-yl]-2-fluoro-N-methylbenzamide
Controlled ProductCAS:1351185-54-0
Formula:
C22H16F4N4O3S
Color and Shape:
Neat
Molecular weight:
492.446
Ref: TR-C778060
250mg | 9,057.00 € |
Estimated delivery in United States, on Wednesday 8 Jan 2025
ONC1-13B
CAS:1351185-54-0
ONC1-13B, an androgen receptor antagonist, is used potentially for the treatment of prostate cancer.
Formula:
C22H16F4N4O3S
Purity:
99.45% - 99.85%
Color and Shape:
Solid
Molecular weight:
492.45
Ref: TM-T28238
1mg | 273.00 € | ||
5mg | 675.00 € | ||
10mg | 927.00 € | ||
25mg | 1,399.00 € | ||
50mg | 1,852.00 € | ||
100mg | 2,581.00 € |
Estimated delivery in United States, on Thursday 16 Jan 2025
4-[(R)-3-[4-Cyano-3-(trifluoromethyl)phenyl]-4-oxo-2-thioxo-7-oxa-1,3-diazaspiro[4.4]non-1-yl]-2-fluoro-N-methylbenzamide
CAS:1351185-54-0
Please enquire for more information about 4-[(R)-3-[4-Cyano-3-(trifluoromethyl)phenyl]-4-oxo-2-thioxo-7-oxa-1,3-diazaspiro[4.4]non-1-yl]-2-fluoro-N-methylbenzamide including the price, delivery time and more detailed …
Formula:
C22H16F4N4O3S
Purity:
Min. 95%
Molecular weight:
492.4 g/mol
Ref: 3D-BEC18554
5mg | Discontinued | Request information | |
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information | |
50mg | Discontinued | Request information | |
100mg | Discontinued | Request information |